Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G

被引:95
作者
Cen, Shan [2 ,3 ]
Peng, Zong-Gen
Li, Xiao-Yu [2 ,3 ]
Li, Zhuo-Rong
Ma, Jing [2 ,3 ]
Wang, Yue-Ming
Fan, Bo
You, Xue-Fu
Wang, Yu-Ping [1 ]
Liu, Fei [1 ]
Shao, Rong-Guang [1 ]
Zhao, Li-Xun [1 ]
Yu, Liyan [1 ]
Jiang, Jian-Dong [1 ]
机构
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Virol, Beijing 100050, Peoples R China
[2] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada
基金
加拿大健康研究院; 比尔及梅琳达.盖茨基金会; 中国国家自然科学基金;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL VIF PROTEIN; SOR GENE; TYPE-1; VIF; LYMPHOCYTES; INFECTIVITY;
D O I
10.1074/jbc.M109.085308
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
APOBEC3G (hA3G) is a host inhibitor for human immunodeficiency virus, type 1 (HIV-1). However, HIV-1 Vif binds hA3G and induces its degradation. We have established a screening system to discover inhibitors that protect hA3G from Vif-mediated degradation. Through screening, compounds IMB-26 and IMB-35 were identified to be specific inhibitors for the degradation of hA3G by Vif. The inhibitors suppressed HIV-1 replication in hA3G-containing cells but not in those without hA3G. The anti-HIV effect correlated with the endogenous hA3G level. HIV-1 particles from hA3G(+) cells treated with IMB-26/35 contained a hA3G level higher than that from those without IMB-26/35 treatment and showed decreased infectivity. IMB26/35 bound directly to the hA3G protein, suppressed Vif/hA3G interaction, and therefore protected hA3G from Vif-mediated degradation. The compounds were safe with an anti-HIV therapeutic index >200 in vitro. LD50 of IMB-26 in mice was >1000 mg/kg (intraperitoneally). Therefore, IMB-26 and IMB-35 are novel anti-HIV leads working through specific stabilization of hA3G.
引用
收藏
页码:16546 / 16552
页数:7
相关论文
共 20 条
[1]   The interaction between HIV-1 Gag and APOBEC3G [J].
Cen, S ;
Guo, F ;
Niu, MJ ;
Saadatmand, J ;
Deflassieux, J ;
Kleiman, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33177-33184
[2]   THE SOR GENE OF HIV-1 IS REQUIRED FOR EFFICIENT VIRUS TRANSMISSION INVITRO [J].
FISHER, AG ;
ENSOLI, B ;
IVANOFF, L ;
CHAMBERLAIN, M ;
PETTEWAY, S ;
RATNER, L ;
GALLO, RC ;
WONGSTAAL, F .
SCIENCE, 1987, 237 (4817) :888-893
[3]   ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES [J].
GABUZDA, DH ;
LAWRENCE, K ;
LANGHOFF, E ;
TERWILLIGER, E ;
DORFMAN, T ;
HASELTINE, WA ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6489-6495
[4]   Inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationv [J].
Guo, Fei ;
Cen, Shan ;
Niu, Meijuan ;
Saadatmand, Jenan ;
Kleiman, Lawrence .
JOURNAL OF VIROLOGY, 2006, 80 (23) :11710-11722
[5]   A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer [J].
Hu, K ;
Clément, JF ;
Abrahamyan, L ;
Strebel, K ;
Bouvier, M ;
Kleiman, L ;
Mouland, AJ .
JOURNAL OF VIROLOGICAL METHODS, 2005, 128 (1-2) :93-103
[6]   An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 [J].
Jarmuz, A ;
Chester, A ;
Bayliss, J ;
Gisbourne, J ;
Dunham, I ;
Scott, J ;
Navaratnam, N .
GENOMICS, 2002, 79 (03) :285-296
[7]   The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity [J].
Kao, S ;
Khan, MA ;
Miyagi, E ;
Plishka, R ;
Buckler-White, A ;
Strebel, M .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11398-11407
[8]   An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein [J].
Madani, N ;
Kabat, D .
JOURNAL OF VIROLOGY, 1998, 72 (12) :10251-10255
[9]   Small-molecule inhibition of HIV-1 Vif [J].
Nathans, Robin ;
Cao, Hong ;
Sharova, Natalia ;
Ali, Akbar ;
Sharkey, Mark ;
Stranska, Ruzena ;
Stevenson, Mario ;
Rana, Tariq M. .
NATURE BIOTECHNOLOGY, 2008, 26 (10) :1187-1192
[10]   Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G [J].
Rose, KM ;
Marin, M ;
Kozak, SL ;
Kabat, D .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (07) :611-619